Orchid Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma has informed the stock exchanges that its trading window will remain closed starting October 1, 2025, in line with SEBI's insider trading regulations. The window will stay shut until 48 hours after the company declares its unaudited financial results for the second quarter of FY2025-26 (quarter ending September 30, 2025). Insiders and anyone with access to unpublished price-sensitive information are barred from trading in the company's shares during this period. The date of the board meeting to approve the Q2 results will be communicated separately.
This is a routine compliance filing and does not directly affect the stock price. It simply signals that Q2 FY2025-26 results are expected to be announced in the coming weeks, which investors should watch for.